Cargando…
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897647/ https://www.ncbi.nlm.nih.gov/pubmed/35594528 http://dx.doi.org/10.1080/21645515.2022.2065824 |
_version_ | 1784882295284432896 |
---|---|
author | Mohapatra, Ranjan K. El-Shall, Nahed A. Tiwari, Ruchi Nainu, Firzan Kandi, Venkataramana Sarangi, Ashish K. Mohammed, Teroj Abdulrahman Desingu, Perumal Arumugam Chakraborty, Chiranjib Dhama, Kuldeep |
author_facet | Mohapatra, Ranjan K. El-Shall, Nahed A. Tiwari, Ruchi Nainu, Firzan Kandi, Venkataramana Sarangi, Ashish K. Mohammed, Teroj Abdulrahman Desingu, Perumal Arumugam Chakraborty, Chiranjib Dhama, Kuldeep |
author_sort | Mohapatra, Ranjan K. |
collection | PubMed |
description | The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant of SARS-CoV-2, Omicron has instilled serious uncertainties on the effectiveness of humoral adaptive immunity generated by COVID-19 vaccination or an active viral infection as well as the protection provided by antibody-based immunotherapies. Amidst such high public health concerns, the need to carry out booster vaccination has been emphasized. Current evidence reveals the importance of incorporating booster vaccination using several vaccine platforms, such as viral vector- and mRNA-based vaccines, as well as other platforms that are under explorative investigations. Further research is being conducted to assess the effectiveness and durability of protection provided by booster COVID-19 vaccination against Omicron and other SARS-CoV-2 variants. |
format | Online Article Text |
id | pubmed-9897647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-98976472023-02-04 Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update Mohapatra, Ranjan K. El-Shall, Nahed A. Tiwari, Ruchi Nainu, Firzan Kandi, Venkataramana Sarangi, Ashish K. Mohammed, Teroj Abdulrahman Desingu, Perumal Arumugam Chakraborty, Chiranjib Dhama, Kuldeep Hum Vaccin Immunother Coronavirus – Commentary The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant of SARS-CoV-2, Omicron has instilled serious uncertainties on the effectiveness of humoral adaptive immunity generated by COVID-19 vaccination or an active viral infection as well as the protection provided by antibody-based immunotherapies. Amidst such high public health concerns, the need to carry out booster vaccination has been emphasized. Current evidence reveals the importance of incorporating booster vaccination using several vaccine platforms, such as viral vector- and mRNA-based vaccines, as well as other platforms that are under explorative investigations. Further research is being conducted to assess the effectiveness and durability of protection provided by booster COVID-19 vaccination against Omicron and other SARS-CoV-2 variants. Taylor & Francis 2022-05-20 /pmc/articles/PMC9897647/ /pubmed/35594528 http://dx.doi.org/10.1080/21645515.2022.2065824 Text en © 2022 Government College of Engineering. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Coronavirus – Commentary Mohapatra, Ranjan K. El-Shall, Nahed A. Tiwari, Ruchi Nainu, Firzan Kandi, Venkataramana Sarangi, Ashish K. Mohammed, Teroj Abdulrahman Desingu, Perumal Arumugam Chakraborty, Chiranjib Dhama, Kuldeep Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
title | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
title_full | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
title_fullStr | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
title_full_unstemmed | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
title_short | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
title_sort | need of booster vaccine doses to counteract the emergence of sars-cov-2 variants in the context of the omicron variant and increasing covid-19 cases: an update |
topic | Coronavirus – Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897647/ https://www.ncbi.nlm.nih.gov/pubmed/35594528 http://dx.doi.org/10.1080/21645515.2022.2065824 |
work_keys_str_mv | AT mohapatraranjank needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT elshallnaheda needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT tiwariruchi needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT nainufirzan needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT kandivenkataramana needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT sarangiashishk needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT mohammedterojabdulrahman needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT desinguperumalarumugam needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT chakrabortychiranjib needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT dhamakuldeep needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate |